Gilead Sciences (GILD) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
26.7%

Gilead Sciences (GILD) earned a return on invested capital of 26.7% in fiscal 2025 (the year ended December 31, 2025). That is 5.4 percentage points higher than the 21.3% of fiscal 2024. Figures as of 18 Nov 2026, 08:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
26.7%
Change on fiscal 2024
+5.4 pts
Highest on record
26.7%fiscal 2025
Lowest on record
17.8%fiscal 2023
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Gilead Sciences return on invested capital (ROIC), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 26.7% in fiscal 2025 and the lowest 17.8% in fiscal 2023. The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 21.3%.

History · 4 fiscal years

Return on invested capital by fiscal year

Gilead Sciences return on invested capital (ROIC), year by year

Gilead Sciences (GILD) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
202526.7% 5.4 pts up
202421.3% 3.5 pts up
202317.8% 3.7 pts down
202221.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Gilead Sciences and comparable companies
CompanyReturn on invested capitalFiscal year
Thermo Fisher Scientific TMO9.1%2025
Amgen AMGN14.4%2025
Gilead Sciences GILD26.7%2025
Abbott Laboratories ABT10.9%2025
Novo Nordisk NVO33.6%2025
Pfizer PFE12.7%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GILD

Gilead Sciences, figure by figure

Gilead Sciences (GILD) overview: price, valuation and scorecardAll health care companies by market value

Gilead Sciences return on invested capital (ROIC): questions and answers

What is Gilead Sciences's return on invested capital?

Gilead Sciences (GILD) earned a return on invested capital of 26.7% in fiscal 2025 (the year ended December 31, 2025). That is 5.4 percentage points higher than the 21.3% of fiscal 2024.

Is Gilead Sciences's return on invested capital high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 21.3%.

What are the highest and lowest return on invested capital figures on record for Gilead Sciences?

Across the 4 fiscal years on record (2022–2025), the highest was 26.7% in fiscal 2025 and the lowest 17.8% in fiscal 2023.

How is Gilead Sciences's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Gilead Sciences (GILD) return on invested capital (ROIC)”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.